by admin | Feb 3, 2021 | COVID-19
By the Autoimmune Hepatitis Association The American Association for the Study of Liver Diseases (AASLD) released their expert panel consensus on vaccines to prevent COVID-19 infections in patients with liver disease on February 2, 2021. This statement is in agreement...
by admin | Jan 28, 2021 | COVID-19
By the Autoimmune Hepatitis Association The arrival of new variants of the coronavirus in the US have some experts advising that now is the time to consider what type of mask you’re wearing and how many. Not only is there significant community spread of the...
by admin | Jan 12, 2021 | COVID-19
By Craig Lammert, M.D.AIHA Executive Director The first few days of 2021 gave me a different view of medicine than I am accustomed to. My institution asked me to “redeploy” as an internal medicine hospitalist at IU Health University Hospital in Indianapolis. The...
by admin | Dec 17, 2020 | Uncategorized
By Craig Lammert, M.D. Steroids are typically used to rapidly control liver inflammation seen in autoimmune hepatitis. Ultimately, a goal of AIH care is to find a chronic immunosuppressive medication regimen that will be well tolerated by patients, control...
by admin | Dec 7, 2020 | COVID-19
By the Autoimmune Hepatitis Association Two SARS-Cov-2 vaccines were submitted to the FDA for emergency use authorization near the end of November 2020. Many believe that these vaccines designed to protect against the virus that causes COVID-19 will soon be approved....
Recent Comments